Cited by 904Ocular Diseases and Behçet’s SyndromeOcular Infections and TreatmentsRetinal Diseases and Treatments

Causes and frequency of blindness in patients with intraocular inflammatory disease.

Open access
Rothova, A, Suttorp-van Schulten, M S, Frits Treffers, W, Kijlstra, A·1996·British Journal of Ophthalmology

Abstract

AIMS/BACKGROUND: Uveitis, an intraocular inflammatory disease, is a significant cause of visual impairment. It is not known how many patients with uveitis will retain visual acuity and how many develop visual impairment or even blindness. The aim of this study was to assess the frequency of blindness in patients with uveitis and, more specifically, to identify the clinical profile of patients at risk for visual loss. METHODS: A cross sectional and retrospective study of 582 patients with uveitis who visited the ophthalmology departments of two university hospitals in the Netherlands was performed. RESULTS: Within the group of 582 patients, 203 (35%) exhibited blindness or visual impairment; bilateral legal blindness developed in 22 (4%) patients, 26 (4.5%) had one blind eye with visual impairment of the other, and nine (1.5%) had bilateral visual impairment. Unilateral blindness developed in 82 (14%) patients, whereas 64 (11%) exhibited unilateral visual impairment. The most important cause of both blindness and visual impairment was cystoid macular oedema (29% and 41%, respectively). Complications of uveitis were encountered in more than half of the patients and 23% underwent one or more surgical procedures. When the patients were subdivided according to anatomical site, those with panuveitis had the worst visual prognosis. The systemic diseases associated with a poor visual prognosis were juvenile chronic arthritis and sarcoidosis. Ocular toxoplasmosis was the most frequent cause of unilateral visual loss. CONCLUSIONS: Cystoid macular oedema is the most frequent complication of uveitis and its occurrence plays a decisive role in the visual outcome of this disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bjo.80.4.332

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intraocular inflammation remains a major cause of vision loss.

    “Yet, despite immune privilege, intraocular inflammation remains a major cause of vision loss—underscoring the limitations of our current understanding of the phenomenon.”

    From Investigation of Cas9 Antibodies in the Human Eye (2022) · cites this paper as [13]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. Vadot E, Barth E, Billet P. Epidemiology of uveitis -pre- liminary results of a prospective study in Savoy. In: Saari KM, ed. Uveitis update. Amsterdam: Elsevier, 1984: 13-6.
  2. Bennet PH, Burch TA. New York symposium on popula- tion studies in the rheumatic diseases. New diagnostic criteria. Bull Rheum Dis 1967; 17: 453-8.
  3. McGavin M. Reaching for high standards of eye care. Community Eye Health 1993; 6: 1-2.
  4. Loewer-Sieger DH, Rothova A, Koppe JG, Kijlstra A. Congenital toxoplasmosis: a prospective study based on 1821 pregnant women. In: Saari KM, ed. Uveitis update. Amsterdam: Elsevier, 1984: 203-7.
  5. Wilson CB, Remington JS, Stagno S, Reynold DW. Development ofadverse sequelae in children born with sub- clinical toxoplasma infection. Pediatrics 1980; 66: 767-74.
  6. Cochereau-Massin I, Wechsler B, Le Hoang P, Le Thi Huong Du, Girard B, Rousselie F, et al. Prognostic ocu- laire de la maladie de Behcet. J Fr Ophtalmol 1992; 15: 343-47.

Cited by

Sorted by citations

Authors
Rothova, A., Suttorp-van Schulten, M. S., Frits Treffers, W., & Kijlstra, A.
Affiliations
University Medical Center Utrecht (NL)
Venue
British Journal of Ophthalmology
Publisher
BMJ
Published
1996-04-01
Volume
80
Issue
4
Pages
332-336
ISSN
0007-1161 (ISSN-L)
OpenAlex
W1979534828
Cited by
904
References
36
Citations by year
2026: 30 · 2025: 36 · 2024: 27 · 2023: 44 · 2022: 47 · 2021: 59 · 2020: 45 · 2019: 48 · 2018: 42 · 2017: 43 · 2016: 56 · 2015: 48 · 2014: 40 · 2013: 36 · 2012: 36
FWCI
8.00
Type
journal article
Language
en
Open access
Locations
  • British Journal of Ophthalmology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
uveitis, blindness, visual impairment, cystoid macular edema, panuveitis, ocular toxoplasmosis, juvenile idiopathic arthritis, sarcoidosis, visual prognosis, uveitis complications, surgical treatment
MeSH terms
Arthritis, Juvenile, Blindness, Cross-Sectional Studies, Humans, Macular Edema, Netherlands, Retrospective Studies, Risk Factors, Sarcoidosis, Uveitis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review